Manufacturers Life Insurance Company, The Geron Corp Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Geron Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 448,886 shares of GERN stock, worth $781,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares
448,886
Previous 695,535 35.46%
Holding current value
$781,061
Previous $3.16 Million 49.67%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$3.3 - $4.44 $813,941 - $1.1 Million
-246,649 Reduced 35.46%
448,886 $1.59 Million
Q3 2024

Nov 13, 2024
SELL
$4.17 - $4.99 $919,126 - $1.1 Million
-220,414 Reduced 24.06%
695,535 $3.16 Million
Q2 2024

Aug 14, 2024
BUY
$3.1 - $5.09 $1.71 Million - $2.82 Million
553,081 Added 152.42%
915,949 $3.88 Million
Q1 2024

May 14, 2024
BUY
$1.75 - $3.44 $178,571 - $351,021
102,041 Added 39.12%
362,868 $1.2 Million
Q4 2023

Feb 13, 2024
BUY
$1.74 - $2.31 $2,263 - $3,005
1,301 Added 0.5%
260,827 $550,000
Q3 2023

Nov 15, 2023
BUY
$2.11 - $3.28 $127,104 - $197,583
60,239 Added 30.23%
259,526 $550,000
Q2 2023

Aug 11, 2023
BUY
$1.97 - $3.69 $117,412 - $219,924
59,600 Added 42.67%
199,287 $639,000
Q1 2023

May 15, 2023
BUY
$2.14 - $3.4 $16,124 - $25,619
7,535 Added 5.39%
147,222 $319,000
Q4 2022

Aug 11, 2023
SELL
$2.03 - $2.42 $5,740 - $6,843
-2,828 Reduced 1.98%
139,687 $338,000
Q4 2022

Feb 13, 2023
SELL
$2.03 - $2.42 $5,740 - $6,843
-2,828 Reduced 1.98%
139,687 $338,000
Q3 2022

Aug 11, 2023
SELL
$1.67 - $2.94 $8,057 - $14,185
-4,825 Reduced 3.27%
142,515 $333,000
Q3 2022

Nov 03, 2022
SELL
$1.67 - $2.94 $8,057 - $14,185
-4,825 Reduced 3.27%
142,515 $333,000
Q2 2022

Aug 11, 2023
BUY
$1.19 - $1.65 $15,514 - $21,511
13,037 Added 9.71%
147,340 $228,000
Q2 2022

Aug 15, 2022
BUY
$1.19 - $1.65 $15,514 - $21,511
13,037 Added 9.71%
147,340 $228,000
Q1 2022

Aug 11, 2023
SELL
$0.99 - $1.6 $12,789 - $20,670
-12,919 Reduced 8.78%
134,303 $182,000
Q1 2022

May 20, 2022
SELL
$0.99 - $1.6 $38,062 - $61,515
-38,447 Reduced 22.26%
134,303 $183,000
Q4 2021

Feb 16, 2022
SELL
$1.22 - $1.72 $7,629 - $10,756
-6,254 Reduced 3.49%
172,750 $211,000
Q3 2021

Nov 12, 2021
SELL
$1.2 - $1.5 $11,679 - $14,599
-9,733 Reduced 5.16%
179,004 $245,000
Q2 2021

Aug 12, 2021
BUY
$1.25 - $1.83 $18,465 - $27,032
14,772 Added 8.49%
188,737 $266,000
Q1 2021

May 03, 2021
SELL
$1.52 - $2.1 $5,668 - $7,830
-3,729 Reduced 2.1%
173,965 $275,000
Q4 2020

Feb 12, 2021
BUY
$1.55 - $2.05 $25,334 - $33,507
16,345 Added 10.13%
177,694 $283,000
Q3 2020

Nov 09, 2020
BUY
$1.59 - $2.19 $72,887 - $100,391
45,841 Added 39.69%
161,349 $281,000
Q2 2020

Aug 10, 2020
SELL
$1.05 - $2.18 $8,277 - $17,184
-7,883 Reduced 6.39%
115,508 $243,000
Q1 2020

May 15, 2020
BUY
$0.89 - $1.49 $14,452 - $24,196
16,239 Added 15.16%
123,391 $147,000
Q4 2019

Feb 14, 2020
SELL
$1.27 - $1.54 $11,454 - $13,889
-9,019 Reduced 7.76%
107,152 $146,000
Q2 2019

Aug 14, 2019
SELL
$1.37 - $2.02 $4,457 - $6,573
-3,254 Reduced 2.72%
116,171 $164,000
Q1 2019

May 13, 2019
SELL
$1.01 - $1.83 $1,495 - $2,710
-1,481 Reduced 1.22%
119,425 $198,000
Q4 2018

Feb 14, 2019
BUY
$0.98 - $1.85 $10,065 - $19,001
10,271 Added 9.28%
120,906 $121,000
Q3 2018

Nov 14, 2018
SELL
$1.76 - $6.38 $19,372 - $70,224
-11,007 Reduced 9.05%
110,635 $195,000
Q2 2018

Aug 14, 2018
BUY
$3.29 - $4.82 $25,678 - $37,620
7,805 Added 6.86%
121,642 $418,000
Q1 2018

May 15, 2018
SELL
$1.81 - $5.98 $7,739 - $25,570
-4,276 Reduced 3.62%
113,837 $484,000
Q4 2017

Feb 08, 2018
SELL
$1.8 - $2.32 $2,658 - $3,426
-1,477 Reduced 1.24%
118,113 $213,000
Q3 2017

Nov 14, 2017
BUY
$1.99 - $2.65 $237,984 - $316,913
119,590
119,590 $260,000

Others Institutions Holding GERN

# of Institutions
306
Shares Held
465M
Call Options Held
1.07M
Put Options Held
648K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $657M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email